| Systemic therapy for melanoma: ASCO guideline R Seth, H Messersmith, V Kaur, JM Kirkwood, R Kudchadkar, ... Journal of Clinical Oncology 38 (33), 3947-3970, 2020 | 283 | 2020 |
| Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib V Kaur, A Swami Annals of hematology 96 (7), 1175-1184, 2017 | 84 | 2017 |
| Systemic therapy for melanoma: ASCO guideline update R Seth, SS Agarwala, H Messersmith, KC Alluri, PA Ascierto, MB Atkins, ... Journal of Clinical Oncology 41 (30), 4794-4820, 2023 | 83 | 2023 |
| Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years V Kaur, A Swami, D Alapat, AO Abdallah, P Motwani, LF Hutchins, ... Hematology 23 (1), 17-24, 2018 | 72 | 2018 |
| Spicy seizure S Pant, B Dholaria, V Kaur, S Ramavaram, M Ukor, A Deshmukh, ... The American journal of the medical sciences 344 (1), 67-68, 2012 | 69 | 2012 |
| von Willebrand disease: a concise review and update for the practicing physician A Swami, V Kaur Clinical and applied thrombosis/hemostasis 23 (8), 900-910, 2017 | 60 | 2017 |
| Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck … JP Machiels, Y Tao, L Licitra, B Burtness, M Tahara, D Rischin, G Alves, ... The Lancet Oncology 25 (5), 572-587, 2024 | 43 | 2024 |
| Pre-diagnosis blood glucose and prognosis in women with breast cancer B Monzavi-Karbassi, R Gentry, V Kaur, ER Siegel, F Jousheghany, ... Cancer & metabolism 4, 1-6, 2016 | 29 | 2016 |
| Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia V Kaur, P Mehta, J Johnsurd, R Govindarajan Blood, The Journal of the American Society of Hematology 124 (23), 3503-3505, 2014 | 26 | 2014 |
| Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63) CL Slingluff Jr, GR Petroni, KA Chianese-Bullock, NA Wages, WC Olson, ... Journal for Immunotherapy of Cancer 9 (1), 2021 | 20 | 2021 |
| Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64) RD Vavolizza, GR Petroni, IS Mauldin, KA Chianese-Bullock, WC Olson, ... Journal for Immunotherapy of Cancer 10 (9), 2022 | 10 | 2022 |
| Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: a case report V Kaur, A Swami Journal of Oncology Pharmacy Practice 23 (3), 235-239, 2017 | 10 | 2017 |
| Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease AOA Abdallah, D Alapat, V Kaur, S Atrash Journal of Oncology Pharmacy Practice 26 (5), 1128-1133, 2020 | 8 | 2020 |
| Addressing opioid-associated constipation using quality oncology practice initiative scores and plan-do-study-act cycles V Kaur, S Haider, A Sasapu, P Mehta, K Arnaoutakis, I Makhoul Journal of Oncology Practice 13 (1), e91-e97, 2017 | 8 | 2017 |
| Aspergillus brain abscess. N Bhaskar, K Mohammad, V Kaur The Journal of the Arkansas Medical Society 110 (2), 41-42, 2013 | 7 | 2013 |
| Prognostic significance of extra-nodal extension and positive surgical margins in HPV positive oropharyngeal squamous cell carcinoma V Kaur, A Rooney, BJ Horton American Journal of Otolaryngology 44 (4), 103877, 2023 | 5 | 2023 |
| Image Diagnosis: Splenic Infarction Associated with Oral Contraceptive Pills in a Healthy Young Woman AO Abdallah, V Kaur, F Mahmoud, P Motwani The Permanente Journal 21, 2017 | 5 | 2017 |
| Systemic Therapy for Melanoma: ASCO Guideline., 2020, 38 R Seth, H Messersmith, V Kaur, JM Kirkwood, R Kudchadkar, ... DOI: https://doi. org/10.1200/JCO 20, 3947-3970, 0 | 5 | |
| Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors J Wang, O Elghawy, B Kurpiel, V Kaur Clinical Journal of Gastroenterology 16 (6), 807-814, 2023 | 4 | 2023 |
| 656MO Phase I study of M6620 (VX-970, berzosertib) in combination with cisplatin and XRT in patients with locally advanced head and neck squamous cell carcinoma A Bhatia, Z Chen, J Bruce, CE Steuer, DP Zandberg, JW Riess, D Mitchell, ... Annals of Oncology 33, S842, 2022 | 3 | 2022 |
